PUM2
OFFICE ACTION ISSUED POU2
06/29/2026
Back to search
Official data from USPTO
MEDIVIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/29/2026
Trademark type
Word
Nice classes
5
Filing date
10/03/2018
Registration date
11/05/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2019
Last transaction
06/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
SG
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pacific Pharmaceuticals Pte Ltd
Representatives
Sang N. Dang Blue Capital Law Firm, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Mineral dietary supplements for humans; pharmaceutical drugsantipyreticsanti-infectivesantineoplasticsdiureticspharmaceutical preparations for the treatment of immune system disordersdisorders of the central nervous systemendocrine disordersgastrointestinal diseasesdermatological diseasesinfectious diseasescardiovascular diseasesrespiratory diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/21/2026
PUM1
OFFICE ACTION ISSUED POU1
03/21/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
03/03/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/04/2020
FIMP
FINAL DISPOSITION PROCESSED
03/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2019
PUBO
PUBLISHED FOR OPPOSITION
08/20/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/16/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/31/2019
NPUB
NOTICE OF PUBLICATION
07/31/2019
ALIE
ASSIGNED TO LIE
07/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2019
RFNP
REFUSAL PROCESSED BY IB
02/16/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/31/2019
RFRR
REFUSAL PROCESSED BY MPU
01/31/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/19/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/18/2019
CNRT
NON-FINAL ACTION WRITTEN
01/17/2019
DOCK
ASSIGNED TO EXAMINER
01/15/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/10/2019
Continuous trademark protection
Get notified about every new filing that threatens MEDIVIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.